Onychocryptosis associated with the treatment of onychomycosis.
With the advent of effective oral therapies for onychomycosis, there have been anecdotal reports of an increased incidence of onychocryptosis associated with the use of these new agents. The authors undertook a chart review of 100 consecutive patients treated for onychomycosis in a private medical practice to determine the incidence of onychocryptosis. A total of 37 of these patients (37%) developed paronychia ranging from simple pain to a severe inflammatory response with redness, drainage, and granuloma formation. Of these, 19 patients (19%) required surgical procedures to control onychocryptotic symptoms. Podiatric physicians should be aware that ingrown toenails may be an adverse consequence of effective treatment for onychomycosis.
Connelley
L K
LK
West Little Rock Foot Clinic, AR 72205, USA.
Dinehart
S M
SM
McDonald
R
R
D000284:Administration, Oral; D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009263:Nails, Ingrown / Q000139:chemically induced* / Q000150:complications; D014009:Onychomycosis / Q000188:drug therapy*
D000935:Antifungal Agents